Name | [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid |
---|---|
Synonyms |
2,6-Diisopropylphenyl [(2,4,6-triisopropylphenyl)acetyl]sulfamate
Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester [2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate 2,6-di(propan-2-yl)phenyl {[2,4,6-tri(propan-2-yl)phenyl]acetyl}sulfamate Avasimibe CI-1011 |
Description | Avasimibe is an oral inhibitor of acyl-Coenzyme A:cholesterol acyltransferase (ACAT) with IC50s of 24 and 9.2 µM for ACAT1 and ACAT2, respectively. |
---|---|
Related Catalog | |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Melting Point | 178-180° (Lee); mp 169.5-170.4° (Dozeman) |
Molecular Formula | C29H43NO4S |
Molecular Weight | 501.721 |
Exact Mass | 501.291290 |
PSA | 80.85000 |
LogP | 9.34 |
Appearance | white to tan |
Index of Refraction | 1.529 |
Storage condition | room temp |
Water Solubility | DMSO: ≥40mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
RIDADR | NONH for all modes of transport |
---|---|
HS Code | 2935009090 |
~77% 166518-60-1 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
~% 166518-60-1 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
~% 166518-60-1 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
~% 166518-60-1 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
~% 166518-60-1 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
~% 166518-60-1 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
Precursor 7 | |
---|---|
DownStream 0 |
HS Code | 2935009090 |
---|---|
Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |